figshare
Browse
gnpl_a_901323_sm4922.doc (2.71 MB)

Proceraside A, a new cardiac glycoside from the root barks of Calotropis procera with in vitro anticancer effects

Download (0 kB)
Version 3 2014-08-18, 13:17
Version 2 2014-08-18, 13:17
Version 1 2014-08-18, 13:17
journal contribution
posted on 2014-08-18, 13:17 authored by S.R.M. Ibrahim, G.A. Mohamed, L.A. Shaala, L. Moreno, Y. Banuls, R. Kiss, D.T.A. Youssef

We have studied the ethyl acetate fraction of the methanolic extract of the root barks of Calotropis procera (Asclepiadaceae) from Egypt. Bioassay-directed fractionation and final purification of the extract resulted in the identification of a new cardenolide glycoside named proceraside A (1) together with two known compounds, frugoside (2) and calotropin (3). Their structures were elucidated by extensive NMR studies and mass spectrometric data. The in vitro cytotoxicity of the isolated compounds was evaluated against A549 non-small cell lung cancer, U373 glioblastoma and PC-3 prostate cancer cell lines. They showed potent activity against the tested cancer cell lines with IC50 ranging from 0.005 to 0.3 μg/mL. Cisplatin was used as positive control.

History

Usage metrics

    Natural Product Research

    Categories

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC